Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: Feb 25, 2011

IDEX Corporation Successfully Completes Tender Offer for Microfluidics International Corporation Shares

(Nanowerk News) IDEX Corporation today announced the successful completion of the tender offer by its wholly-owned subsidiary, Nano Merger Sub, Inc., for all outstanding shares of common stock of Microfluidics International Corporation at a price of $1.35 per share, net to the seller in cash, without interest but subject to any applicable tax withholding. The tender offer expired at 12:00 midnight, New York City time, on Thursday, February 24, 2011.
The depositary for the tender offer has advised IDEX that, as of the expiration of the tender offer, approximately 6,875,929 shares were validly tendered and not withdrawn in the tender offer, representing approximately 65.92 percent of Microfluidics' issued and outstanding shares. All shares that were validly tendered and not withdrawn during the initial offering period have been accepted for payment in accordance with the terms of the tender offer and Nano Merger Sub, Inc. will promptly pay for such shares. The depositary has also advised IDEX that it has received commitments to tender approximately 64,802 additional shares under the guaranteed delivery procedures described in the tender offer. As a result of the purchase of shares in the tender offer, IDEX has sufficient voting power to approve the merger and adopt the merger agreement without the affirmative vote of any other Microfluidics' stockholder. In the merger, each share not previously purchased in the tender offer (other than shares held by holders who properly exercise their appraisal rights under applicable Delaware law) will be converted into the right to receive the same $1.35 per share price, without interest and subject to applicable tax withholding, that was paid in the tender offer.
IDEX also announced that Nano Merger Sub, Inc. has commenced a subsequent offering period for its tender offer to acquire all of the remaining untendered and outstanding shares of common stock of Microfluidics. This subsequent offering period will expire at 5:00 p.m., New York City time, on March 3, 2011, unless extended.
During the subsequent offering period, any shares validly tendered (which were not previously accepted for payment in the initial offering period) will be accepted immediately for payment, and tendering stockholders will thereafter promptly be paid $1.35 in cash for each share of Microfluidics' common stock tendered, without interest but subject to any applicable tax withholding. This is the same amount per share that was offered and paid in the initial offering period.
Stockholders of Microfluidics who desire to promptly receive the offer consideration are urged to tender their shares in the subsequent offering period so that they may receive payment of the $1.35 per share cash offer price on an expedited basis, rather than experiencing the substantial delay in payment that would be attendant to payment following the possible long-form merger described below. Stockholders who tender into the subsequent offering period will not be able to exercise their appraisal rights under applicable Delaware law, as described in the Offer to Purchase.
Following the expiration of the subsequent offering period, Nano Merger Sub, Inc. will acquire all of the remaining outstanding shares by means of a merger under Delaware law. If IDEX, through Nano Merger Sub, Inc., owns 90% or more of the aggregate number of Microfluidics' shares outstanding following the expiration of the subsequent offering period, the merger will be implemented on an expedited basis pursuant to the short-form merger procedure available under Delaware law that authorizes the completion of the merger without a vote or meeting of stockholders of Microfluidics. If a short-form merger cannot be effected, IDEX and Microfluidics will as soon as is practicable file proxy materials with the Securities and Exchange Commission (the "SEC") pertaining to a stockholder meeting at which a long-form merger would be approved, which meeting will be held following SEC review of those proxy materials and the passage of appropriate notice periods under applicable Delaware law and Microfluidics' bylaws.
Procedures for tendering shares during the subsequent offering period are the same as during the initial offering period with two exceptions: (1) stockholders will not be permitted to tender shares by means of guaranteed delivery and (2) pursuant to Rule 14d-7(a)(2) under the Securities Exchange Act of 1934, as amended, shares tendered during the subsequent offering period may not be withdrawn. In addition, shares tendered during the initial offering period and previously accepted for payment may not be withdrawn during the subsequent offering period. IDEX and Nano Merger Sub, Inc. reserve the right to extend the subsequent offering period in accordance with applicable law, although they have no current intention to do so.
About IDEX
IDEX Corporation is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products built to its customers' exacting specifications. Its products are sold in niche markets to a wide range of industries throughout the world. For further information on IDEX Corporation and its business units, visit the company's Web site at www.idexcorp.com.
Source: IDEX (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
 
 
If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
 
 
These articles might interest you as well: